华纳药厂
(688799)
| 流通市值：39.29亿 | | | 总市值：39.29亿 |
| 流通股本：9380.00万 | | | 总股本：9380.00万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,069,303,325.98 | 738,594,469.49 | 372,901,239.16 | 1,432,788,865.24 |
| 营业收入 | 1,069,303,325.98 | 738,594,469.49 | 372,901,239.16 | 1,432,788,865.24 |
| 二、营业总成本 | 924,380,616.39 | 634,765,915.77 | 321,930,686.51 | 1,210,031,306.71 |
| 营业成本 | 402,683,130.21 | 274,932,507.52 | 133,124,449.33 | 504,552,410.51 |
| 税金及附加 | 18,089,062.56 | 11,746,584.77 | 3,325,361.76 | 19,276,279.45 |
| 销售费用 | 369,270,409.74 | 250,922,657.6 | 138,260,080.17 | 528,096,127.87 |
| 管理费用 | 47,079,440.34 | 32,810,327.22 | 16,965,739.91 | 67,246,494.2 |
| 研发费用 | 100,556,753.85 | 66,469,596.95 | 31,428,966.58 | 103,183,484.71 |
| 财务费用 | -13,298,180.31 | -2,115,758.29 | -1,173,911.24 | -12,323,490.03 |
| 其中:利息收入 | 13,679,371.81 | 1,986,239.56 | 1,145,868.58 | 12,435,534.96 |
| 加:投资收益 | -11,400,345.34 | -4,140,800.94 | -2,848,852.32 | 3,584,532.28 |
| 资产处置收益 | - | - | 0 | 200.27 |
| 资产减值损失(新) | -2,414,760.53 | -2,578,753.14 | -1,159,560.73 | -7,592,780.54 |
| 信用减值损失(新) | 337,550.33 | -2,315,196.38 | -1,095,205.6 | -1,581,700.07 |
| 其他收益 | 32,089,318.32 | 26,499,345.27 | 21,552,389.41 | 19,947,117.55 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 163,534,472.37 | 121,293,148.53 | 67,419,323.41 | 237,114,928.02 |
| 加:营业外收入 | 19,543.6 | 1,912.83 | 1,712.61 | 58,409.39 |
| 减:营业外支出 | 111,505.34 | 91,461.35 | 7,332.47 | 7,293,847.94 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 163,442,510.63 | 121,203,600.01 | 67,413,703.55 | 229,879,489.47 |
| 减:所得税费用 | 24,105,765.5 | 21,738,853.83 | 14,780,438.34 | 36,842,906.91 |
| 六、净利润 | 139,336,745.13 | 99,464,746.18 | 52,633,265.21 | 193,036,582.56 |
| 持续经营净利润 | 139,336,745.13 | 99,464,746.18 | 52,633,265.21 | 193,036,582.56 |
| 归属于母公司股东的净利润 | 158,409,039.22 | 112,793,471.26 | 60,053,057.57 | 211,319,567.71 |
| 少数股东损益 | -19,072,294.09 | -13,328,725.08 | -7,419,792.36 | -18,282,985.15 |
| (一)基本每股收益 | 1.69 | 1.2 | 0.64 | 2.25 |
| (二)稀释每股收益 | 1.69 | 1.2 | 0.64 | 2.25 |
| 九、综合收益总额 | 139,336,745.13 | 99,464,746.18 | 52,633,265.21 | 193,036,582.56 |
| 归属于母公司股东的综合收益总额 | 158,409,039.22 | 112,793,471.26 | 60,053,057.57 | 211,319,567.71 |
| 归属于少数股东的综合收益总额 | -19,072,294.09 | -13,328,725.08 | -7,419,792.36 | -18,282,985.15 |
| 公告日期 | 2024-10-29 | 2024-08-31 | 2024-04-20 | 2024-04-20 |
| 审计意见(境内) | | | | 标准无保留意见 |